Has Mannkind bottomed out?

[joeypotsandpans]

247wallst.com/healthcare-business/2015/05/20/has-mannkind-stock-finally-bottomed-out/

an excerpt that I thought was pretty funny:


Goldman Sachs remained very negative with a Sell rating on May 11, cutting its bearish $3.00 price target down to an even worse $2.00. What investors will want to know, and what many of MannKind’s bullish investors will say and have likely said in chat rooms, is that this analyst reportedly has been very biased in the negative calls. We are staying out of that, but the caveat balances it out.







Read more: Have MannKind Shares Finally Bottomed? (NASDAQ: MNKD) - 24/7 Wall St. 247wallst.com/healthcare-business/2015/05/20/has-mannkind-stock-finally-bottomed-out/#ixzz3ai0EUbQA

Follow us: @247wallst on Twitter | 247wallst on Facebook

[cybergym66]

I, like many, would LOVE for the bottom to be in, but we all have witnessed in the last year or so the "rise and then clobber" efforts of the shorts.  Back in the Spring when Afrezza finally hit the market the price shot up to around $7.78.  We all felt like "YES! Now we're going in the right direction!"   Then GS clobbered us with a downgrade and MNKD hit a new 52 week low.  So though I don't see us going to $3.40 again (hmmm, I said that about $5 too!), I think the shorts aren't quite ready to throw in the towel.  I'd get some ammo ready if/when we approach $4.

[mnholdem]

I'm not sure I will feel comfortable we've reached bottom until I see increasing pps based on a jump in sales. Of course, the right kind of news at the ASM - like announcing a planned approval/launch date for Europe/Japan or the name of the pain med in our pipeline - might help...and might not.

It feels like short interests are still in control until something happens to send them to the exits and brings buying pressure sufficient to sustain a rally.